KZR - Kezar Life Sciences, Inc.
6.475
0.235 3.629%
Share volume: 789
Last Updated: Wed 05 Feb 2025 12:00:04 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.07%
PREVIOUS CLOSE
CHG
CHG%
$6.24
0.24
3.77%
View ratios
| Fiscal Date | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2024-05-09 | 2024-08-13 | 2024-11-12 | |
| Total revenue | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | |||
| Operating expenses | 23.711 M | 21.901 M | 21.948 M | |
| Selling general and admin | 6.539 M | 5.603 M | 5.706 M | |
| Research and development | 17.172 M | 16.298 M | 16.242 M | |
| Total expenses | 23.711 M | 23.383 M | 21.948 M | |
| -1.38% | -6.14% | |||
| Operating income | -23.711 M | -23.383 M | -21.948 M | |
| Ebit | -23.711 M | -23.383 M | -21.948 M | |
| Pretax income | -21.658 M | -21.547 M | -20.313 M | |
| -0.51% | -5.73% | |||
| Income tax | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | |
| Net income | -21.658 M | -21.547 M | -20.313 M | |
| 0.51% | 5.73% |